Miura Global Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Miura Global Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,000	Closed	-$8.31M	–	28
2021 Q4	$8.31M	Sell	11,000 -3,700	-25%	-$2.77M	1.41%	20
2021 Q3	$11M	Buy	14,700 +9,000	+158%	+$6.74M	1.7%	23
2021 Q2	$3.67M	Sell	5,700 -13,300	-70%	-$8.09M	0.67%	29
2021 Q1	$10.9M	Buy	19,000 +5,500	+41%	+$3.26M	1.94%	19
2020 Q4	$7.87M	Sell	13,500 -900	-6%	-$513K	1.49%	22
2020 Q3	$7.42M	Sell	14,400 -9,600	-40%	-$4.86M	2.1%	16
2020 Q2	$10.8M	Sell	24,000 -16,000	-40%	-$7.06M	2.86%	12
2020 Q1	$14M	Sell	40,000 -15,000	-27%	-$5.52M	3.63%	12
2019 Q4	$20.4M	Sell	55,000 -20,000	-27%	-$7.05M	3.5%	12
2019 Q3	$25M	Buy	+75,000	New	+$24.5M	4.39%	10

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Miura Global Management's BIO Position: Q1 2022 in Review

Miura Global Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2022, closing a stake of 11,000 shares — an estimated $8.31M sold.

Miura Global Management first reported a position in BIO in Q3 2019 and held it in 10 quarters. The position peaked at $25M in Q3 2019. 514 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

Miura Global Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2022 after selling out during the quarter.
Miura Global Management sold 11,000 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $8.31M.
Miura Global Management first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 10 quarters.
Miura Global Management's Bio-Rad Laboratories Class A position peaked at $25M in Q3 2019.
514 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on Miura Global Management's 13F filing for Q1 2022, filed 16 May 2022.